Bvf Inc Ovid Therapeutics Inc. Transaction History

Bvf Inc

$3.34 Billion
Q1 2024

A detailed history of Bvf Inc transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Bvf Inc holds 3,853,818 shares of OVID stock, worth $2.97 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

3,853,818

Previous 6,851,051 43.75%

Holding current value

$2.97 Million

Previous $22.1 Million 46.72%

% of portfolio

0.35%

Previous 0.58%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.72 - $4.04 $8.15 Million - $12.1 Million	-2,997,233 Reduced 43.75%	3,853,818 $11.8 Million
Q1 2022 May 16, 2022	BUY	$2.65 - $3.49 $583,000 - $767,800	220,000 Added 3.32%	6,851,051 $21.5 Million
Q2 2021 Aug 16, 2021	BUY	$3.3 - $4.49 $704,550 - $958,615	213,500 Added 3.33%	6,631,051 $25.9 Million
Q1 2021 May 17, 2021	BUY	$2.42 - $4.47 $4.59 Million - $8.47 Million	1,895,500 Added 41.92%	6,417,551 $25.8 Million
Q4 2020 Feb 12, 2021	BUY	$2.28 - $6.84 $2.05 Million - $6.16 Million	900,000 Added 24.85%	4,522,051 $10.4 Million

Q3 2020 Nov 13, 2020	BUY	$5.39 - $8.24 $6.63 Million - $10.1 Million	1,229,900 Added 51.41%	3,622,051 $20.8 Million
Q2 2020 Aug 14, 2020	BUY	$2.67 - $7.91 $2.95 Million - $8.75 Million	1,106,147 Added 86.01%	2,392,151 $17.6 Million
Q1 2020 May 15, 2020	BUY	$2.03 - $4.35 $1.12 Million - $2.4 Million	551,703 Added 75.13%	1,286,004 $3.83 Million
Q4 2019 Feb 14, 2020	SELL	$2.08 - $5.06 $3.3 Million - $8.03 Million	-1,586,935 Reduced 68.37%	734,301 $3.05 Million
Q3 2019 Nov 14, 2019	SELL	$1.76 - $3.51 $2.22 Million - $4.43 Million	-1,262,000 Reduced 35.22%	2,321,236 $7.52 Million
Q2 2019 Aug 14, 2019	BUY	$1.59 - $2.14 $461,475 - $621,105	290,236 Added 8.81%	3,583,236 $6.63 Million
Q1 2019 May 15, 2019	BUY	$1.77 - $3.56 $5.83 Million - $11.7 Million	3,293,000 New	3,293,000 $5.83 Million

Others Institutions Holding OVID

# of Institutions

Shares Held

43.2M

Call Options Held

5.9K

Put Options Held

300

View Full List

About Ovid Therapeutics Inc.

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $54.2M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

More about OVID

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Account